Silva Pharmaceuticals Balance Sheet

Financials in millions BDT. Fiscal year is July - June.

Millions BDT. Fiscal year is Jul - Jun.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Cash & Equivalents	37.38	38.77	38.69	28.64	36.43	58.66
Short-Term Investments	74.21	64.03	88.8	152.72	225.04	211.67
Cash & Short-Term Investments	111.59	102.8	127.49	181.37	261.47	270.33
Cash Growth	-18.51%	-19.37%	-29.70%	-30.64%	-3.28%	12.90%
Accounts Receivable	208.99	229.47	255.72	257.35	255.05	269.91
Other Receivables	0.33	0.14	0.41	1.97	2.56	2.3
Receivables	209.32	229.62	256.13	259.32	257.61	272.21
Inventory	406.44	443.01	493.2	493.72	482.29	464.18
Other Current Assets	63.11	54.4	62.69	66.02	61.79	68.21
Total Current Assets	790.47	829.84	939.52	1,000	1,063	1,075
Property, Plant & Equipment	1,395	1,420	1,473	1,501	1,480	1,371
Other Intangible Assets	2.3	2.42	1.22	1.36	1.51	1.68
Total Assets	2,187	2,252	2,414	2,503	2,545	2,447
Accounts Payable	14.19	9.97	7.16	6.99	6.9	6.25
Accrued Expenses	9.59	9.76	11.85	12.43	16.25	15.28
Short-Term Debt	29.26	28.22	47.71	55.84	91.01	29.14
Current Portion of Leases	1.04	1.07	1.18	1.42	2.34	5.67
Current Income Taxes Payable	8.77	6.47	5.45	7.9	19.03	30.63
Other Current Liabilities	0.14	0.21	0.82	1.62	2.59	1.52
Total Current Liabilities	62.99	55.7	74.16	86.19	138.11	88.48
Long-Term Leases	1.73	2.31	3.44	4.6	5.75	7.9
Long-Term Deferred Tax Liabilities	81.1	81.27	80.68	77.86	75.68	80.3
Total Liabilities	145.82	139.28	158.28	168.65	219.54	176.68
Common Stock	1,365	1,365	1,365	1,365	1,365	1,365
Retained Earnings	676.55	748.04	890.95	969.08	960.2	905.47
Shareholders' Equity	2,042	2,113	2,256	2,334	2,325	2,270
Total Liabilities & Equity	2,187	2,252	2,414	2,503	2,545	2,447
Total Debt	32.03	31.6	52.33	61.86	99.09	42.71
Net Cash (Debt)	79.57	71.21	75.17	119.51	162.38	227.62
Net Cash Growth	-6.82%	-5.27%	-37.10%	-26.40%	-28.67%	17.48%
Net Cash Per Share	0.58	0.52	0.55	0.88	1.19	1.67
Filing Date Shares Outstanding	136.5	136.5	136.5	136.5	136.5	136.5
Total Common Shares Outstanding	136.5	136.5	136.5	136.5	136.5	136.5
Working Capital	727.48	774.14	865.35	914.23	925.05	986.45
Book Value Per Share	14.96	15.48	16.53	17.10	17.03	16.63
Tangible Book Value	2,039	2,111	2,255	2,333	2,324	2,269
Tangible Book Value Per Share	14.94	15.46	16.52	17.09	17.02	16.62
Land	342.77	342.77	342.77	342.77	342.77	342.77
Buildings	424.09	424.09	424.09	424.09	424.09	424.09
Machinery	1,149	1,149	1,149	1,090	1,072	998.72
Construction In Progress	324.46	323.28	317.67	343.47	274.25	178.47

Source: S&P Global Market Intelligence. Standard template. Financial Sources.